10,491 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Allstate Corp

Allstate Corp bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 10,491 shares of the medical equipment provider’s stock, valued at approximately $5,476,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $31,000. Finally, Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical in the fourth quarter worth $36,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of research reports. Citigroup raised their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Stifel Nicolaus upped their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. Finally, Jefferies Financial Group upped their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Trading Down 3.2 %

Shares of NASDAQ ISRG opened at $491.84 on Friday. The firm has a fifty day simple moving average of $556.28 and a two-hundred day simple moving average of $532.34. The firm has a market capitalization of $175.18 billion, a PE ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.